You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
This Rapid Review is a concise, evidence-based guide to the diagnosis and treatment of rheumatological and musculoskeletal disorders. Covering the basic principles of joint examination and key clinical skills, the book describes more than 100 clinical cases especially chosen to illustrate both commonly occurring and more unusual conditions. Each case presentation replicates a real-life situation in the busy world of a typical clinic and is illustrated with superb quality colour clinical photographs. Following the case presentation, a series of questions are posed to simulate the diagnosis process along with answers to the questions and a final diagnosis. Tables with lab values supplement the...
Every consultant has pearls of wisdom they wish they could share with GPs: knowledge they have acquired from years of experience and evidence-based study, which could lead to improved speed and decision in referral, more efficient use of resources and, overall, better patient care. Instant Wisdom for GPs gathers these pearls together, presenting ten bullet-point gems from a comprehensive range of clinical specialties, together with advice on obscure or overlooked diagnoses, guidance on how to distinguish tricky differentials and tips on prescribing. The content has been thoroughly revised and updated for this second edition. New chapters have been added on alcohol use disorders, behavioural ...
Topic Editor Susan Richards is an employee of Sanofi and owns stock in the corporation. Topic Editor Bernard Maillere declares economic support from pharmaceutical companies (Novartis, Sanofi, and UCB) in the frame of collaborations aiming to evaluate the recognition by human T cells of therapeutic proteins and antibodies.
This reference text presents statistical information, causes and impacts of coronavirus on populations, economics, and environment. The text includes machine learning and deep learning techniques to understand exponential behavior as well as predicting the future reachability of the COVID-19 outbreak. It discusses important concepts including smart sensors for early stage diagnosis, diagnosis of COVID-19 using low power IoT-enabled systems, biomedical imaging and sensor fusion, and electronic solutions for diagnosis, monitoring, and treatment of diseases. Aimed at graduate students and professionals in the field of electrical engineering, electronics and communications engineering, biomedical engineering and nanomaterials, this book discusses fundamental aspects and latest research in the field of COVID-19 covers diagnostics techniques in detail provides overview of the symptoms, preventions, and treatments related to COVID-19 discusses android-based mobile applications helpful in spreading awareness of COVID-19
Thoroughly updated and revised, this new edition reflects the numerous advances in clinical management of patients in the last decade, including new understanding of pathogenesis, a new classification and the considerable advances in therapeutic options for the disease.
Systemic autoinflammatory diseases (SAIDs) are a growing group of rare disorders caused by dysregulation of the innate immune system leading to episodes of organ-specific and systemic inflammation. Autoinflammation as a distinct disease category was first reported in 1999 as a group of monogenic disorders with resultant activation of the inflammasome and cytokine excess, presenting as periodic fever and inflammation in serous membranes. Since this original description, the focus has shifted considerably to the inclusion of complex multifactorial conditions, and more than 30 associated genes have been identified. Disease severity varies from mild to life threatening. Advances in the understanding of the pathogenetic role of interleukin-1, have opened new promising horizons in the treatment of these patients, and significantly altered disease outcome.
Significant progress has been acquired in the treatment of rheumatic conditions with the introduction of biologic therapies, which has enabled better control of disease activity and improved patients' long-term outcome. Apart from several biologic treatments already licensed for use in autoimmune rheumatic conditions, numerous other agents are currently under investigation. This rapid expansion of the therapeutic armamentarium requires a critical analysis of individual biologic options and their clinical indications, in order to facilitate the optimal use of these new therapies. The authors felt that a comprehensive book revisiting all the evidence available regarding the efficacy, cost-effe...